Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma.
about
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paragangliomaIncreased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.Metastatic paraganglioma.Recent developments in the therapy of phaeochromocytoma.Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG.The Challenges of Treating Paraganglioma Patients with (177)Lu-DOTATATE PRRT: Catecholamine Crises, Tumor Lysis Syndrome and the Need for Modification of Treatment ProtocolsAssessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumoursThe norepinephrine transporter and pheochromocytoma.Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasA clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.Sequelae and survivorship in patients treated with (131)I-MIBG therapyHormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.Urinary bladder malignant paraganglioma with vertebral metastasis: a case report with literature review.Combination chemotherapy regimen in a patient with metastatic malignant pheochromocytoma and neurofibromatosis type 1.Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.Radionuclide therapy of adrenal tumors.Pheochromocytomas and paragangliomas in humans and dogs.Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?Malignant pheochromocytoma: state of the field with future projections.Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.Peptide receptor radionuclide therapy for metastatic paragangliomas.Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma.Norepinephrine Transporter as a Target for Imaging and Therapy.
P2860
Q33385556-AF9183E7-11B7-4EAE-810A-D84AAD73CF95Q33948942-6E765C8D-6E9B-4D7B-A461-F07256D443D3Q34480015-DE2B10D1-2A50-478F-BD03-7B0679FFD0E0Q34552883-6FBE5164-746B-4B7F-81E6-53C4D28155C9Q35750737-7305FE6D-896C-4BA3-89FB-DF725301E0E5Q35941125-C8641665-5BF0-4F96-A9A0-679F2806EA5DQ36510103-56EAC6C1-F7B2-47CF-B88A-8925F725CEE4Q36652797-B8EA36F1-581B-4A43-A506-F8A56B253403Q36804496-AD28A788-E407-450D-A12C-BDF30C256ADDQ37002905-548BBAB9-859A-427A-8E48-190065848431Q37081870-FB7B70D4-4719-4705-B5D9-7AFF31ECA73AQ37157606-FF89B58A-FA8D-4EE2-96AC-BAE2979CD1FBQ37353941-D28570C3-CF9A-4F57-896B-570D950B23D2Q37685580-BEA47C6D-974B-497B-B61F-B0EF79B8588FQ37864159-F17B99E1-B104-4884-8441-B3FC3D0E70B8Q37962361-F37F9106-FE0D-41C8-8976-6A2874E72D37Q37990403-41E828E2-2DB2-400C-A804-8880A61DBCDAQ38020428-A4463DC0-70BA-4873-8683-83C97086E951Q39102360-BDB8CA50-F95B-4B59-ADB7-DD2ADCFEBA9AQ40208917-C5A343B9-87EF-4E3F-9A27-A59068E45690Q40270415-F3E6C220-836F-4B10-BB33-607E305C11ADQ40777229-F1729CBC-D95B-4744-9D48-71C55CB99528Q40810595-D0867C20-75E0-47E9-8CC4-1B6F16B9EBD8Q46092379-C3422A47-14F5-4AA3-A74E-B2C2359E857CQ46856513-CD1AE719-AAF5-495B-A9D3-97FDD0A59843Q47867820-B93C6DD8-2FAB-4475-B919-020DB006F83A
P2860
Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@ast
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@en
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@nl
type
label
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@ast
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@en
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@nl
prefLabel
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@ast
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@en
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@nl
P2093
P1433
P1476
Iodine -131 metaiodobenzylguan ...... hromocytoma and paraganglioma.
@en
P2093
Douglas S Tyler
George S Leight
Jerome M Feldman
John A Olson
Jon P Gockerman
Joseph Moore
R Edward Coleman
Shawn D Safford
P304
956-62; discussion 962-3
P356
10.1016/S0039-6060(03)00426-4
P407
P577
2003-12-01T00:00:00Z